MBII - Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q2 2021 Results - Earnings Call Transcript
Marrone Bio Innovations, Inc. (MBII) Q2 2021 Earnings Conference Call August 16, 2021 4:30 PM ET Company Participants Linda Moore – General Counsel Kevin Helash – Chief Executive Officer Sue Cheung – Chief Financial Officer Matti Tiainen – Senior Vice President of International Sales Kevin Hammill – Chief Manufacturing Officer Conference Call Participants Ben Klieve – Lake Street Capital Markets Edlain Rodriguez – Jefferies Gerry Sweeney – Roth Capital Presentation Operator Ladies and gentlemen, thank you for standing by, and welcome to the Marrone Bio Innovations Second Quarter 2021 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduct a question-and-answer session. [Operator Instructions] I would now like to turn the conference over to Ms. Linda Moore, General Counsel. Please go ahead. Linda Moore Good afternoon, everyone, and thank you for joining our call. Welcome to the 2021 second quarter earnings conference call
For further details see:
Marrone Bio Innovations' (MBII) CEO Kevin Helash on Q2 2021 Results - Earnings Call Transcript